4//SEC Filing
Schuetz Thomas J. 4
Accession 0001171843-25-000735
CIK 0001738021other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 10:37 AM ET
Size
5.7 KB
Accession
0001171843-25-000735
Insider Transaction Report
Form 4
Schuetz Thomas J.
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Tax Payment
Common Stock
2025-02-08$3.50/sh−41,687$145,905→ 6,470,825 total
Footnotes (2)
- [F1]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock.
- [F2]125,000 of the shares represent unvested RSUs granted on November 16, 2021. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on November 15, 2022. 250,000 of the shares represent unvested RSUs granted on February 8, 2023. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on February 8, 2024. 478,125 of the shares represent unvested RSUs granted on January 9, 2024. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 9, 2025.
Documents
Issuer
Compass Therapeutics, Inc.
CIK 0001738021
Entity typeother
Related Parties
1- filerCIK 0001591464
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 10:37 AM ET
- Size
- 5.7 KB